Marinus Pharmaceuticals, Inc. (MRNS) Projected Future Earnings

Marinus Pharma (MRNS) - corporate logo

The orphan drug status provides Marinus Pharmaceuticals (MRNS) with exclusive pricing power, which is reflected in the projected financial results. The current value of this indicator is , demonstrating the adaptation of profits to Fed rates. Ganaxolone ensures a stable cash flow and high margins, while primary revenue is based on therapies for rare genetic forms of epilepsy and hospital-based developments.

Marinus Pharma (MRNS): Expected Net Income from 07/04/2022 to 11/18/2026

Analytical breakdowns for Marinus Pharmaceuticals (MRNS)

Basic company analysis:MRNS, Marinus Pharmaceuticals Inc
Core merchandise of Marinus Pharma

The consensus earnings forecast aggregates analyst expectations for the business's future cash flows. The trajectory of the organization's future profitability allows for the filtering of short-term volatility to identify the long-term development vector. This metric assesses capitalization potential through the lens of expected net income. For Marinus Pharmaceuticals (MRNS), this trend depends critically on the timelines for launching anticonvulsant drugs. High debt and regulatory risks make this indicator the primary measure of the issuer's financial stability.

Competitor analysis

BIIB (Biogen) - Projected Future Earnings|Net Profit Forecast NBIX (Neurocrine Biosciences, Inc.)|Projected Future Earnings RGC|Axsome Corp - Net Profit Forecast|Projected Future Earnings ACAD (ACADIA Corp)|XENE: Net Profit Forecast|Viking Therapeutics Inc - Projected Future Earnings|Expected Net Profit Supernus Pharmaceuticals, Inc.|Catalyst Pharmaceuticals Inc (CPRX) - Expected Profit|DNLI (Denali Therapeutics Inc) - Expected Profit|Expected Profit Harmony Biosciences Holdings, Inc.|Expected Profit BHVN|Future Profit AMLX (Amylyx Pharmaceuticals, Inc.)|Future Net Profit TRVI|Expected Profit Praxis Precision Medicines, Inc. PRAX|Anavex Corp - Expected Profit|CBLL: Future Profit|Expected Net Income PRTA (prothena.com)|Alector, Inc. (ALEC) - Expected Profit|Net Profit Forecast ANNX|Expected Profit Omeros Corp.|Neurogene Therapeutics (NGNE) - Company Profit Forecast|Projected Future Earnings ACIU|VYGR (Voyager Therapeutics) - Expected Net Income|Projected Future Earnings NMRA (neumoratx.com)|SCLX: Net Profit Forecast|TVGN - Expected Profit|Expected Net Profit Alpha Cognition Inc.|CGTX: Projected Future Earnings|inhibikase.com (IKT) - Projected Future Earnings|Expected Profit Cassava Sciences Inc|ASRT - Projected Net Profit|Expected Profit Coya (COYA)|Projected Future Earnings VistaGen Therapeutics Inc (VTGN)|Ovid Therapeutics Inc. - Future Profit|Company Profit Forecast Acumen Pharmaceuticals (ABOS)|CervoMed Corporation - Projected Future Earnings|Company Profit Forecast alteritytherapeutics.com ATHE|CLNN: Projected Future Earnings|Expected Net Profit PepGen Corp (PEPG)|Expected Profit Jupiter Neurosciences, Inc.|RLMD: Expected Net Income|Projected Future Earnings ANVS|Future Profit Grace Tx GRCE|Expected Profit Firefly Neuroscience, Inc AIFF|KLTO: Net Profit Forecast|NRSN - Expected Profit|RVPH: Expected Profit|MTVA (MetaVia Inc.) - Future Profit|NeurAxis Inc. (NRXS) - Projected Future Earnings|Expected Profit Helius Medical|Passage Bio, Inc. - Forward Earnings|Future Profit NEUP (Neuphoria)|NERV - Expected Net Profit|Projected Future Earnings ATHA (athira.com)|Projected Future Earnings Addex Therapeutics Ltd ADXN|Alzamend Neuro, Inc. - Projected Future Earnings|CYCN - Projected Future Earnings|PTIX (Protagenic Therapeutics, Inc.) - Future Profit|Expected Net Profit Pasithea (KTTA)|Expected Profit Cortigent|Expected Net Profit Avenue Therapeutics Inc. ATXI|Expected Profit brainstorm-cell.com (BCLI)|Future Profit Cara Therapeutics, Inc CARA|Projected Future Earnings CHRO (chromocell.com)|Expected Net Income ELYM|Intra-Cellular Therapies Inc. - Projected Future Earnings|Expected Net Profit Longboard Pharmaceuticals Inc|NKGN: Projected Future Earnings|NeuroBo Pharma (NRBO) - Projected Future Earnings|Future Profit SAGE|Net Profit Forecast SNPX (Synaptogenix, Inc.)|Expected Profit Trevena, Inc (TRVN)|VIGL (Vigil Neuroscience Inc.) - Expected Net Income|Expected Profit Anew Medical WENA|Future Net Profit CERE (Cerevel)